The results showed that DIM could inhibit the expression of CCl4-induced TGF-β1 and Smad 2/3, suggesting that DIM could suppress the progression of CCl4-induced liver fibrosis by inhibiting the TGF-β1 and Smad3 signaling pathways. The gene discussed is TGFB1; the disease is Hepatic fibrosis.